Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barba

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 10, 2024
Advancing Equitable Kidney Care Through Population Health Approaches in Los Angeles County's Safety Net SystemKamyar Kalantar-Zadeh, Evan A Raff, Chyi-Chyi Chong, et al.
Biomarker Research|July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics studyE Krasniqi, A Sacconi, D Marinelli, et al.
Expert Review of Vaccines|April 12, 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesP Vici, L Pizzuti, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinomaS Scalera, B Ricciuti, M Mazzotta, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2011
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohortM Barba, F Sperati, S Stranges, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 10, 2024
Advancing Equitable Kidney Care Through Population Health Approaches in Los Angeles County's Safety Net SystemKamyar Kalantar-Zadeh, Evan A Raff, Chyi-Chyi Chong, et al.
Biomarker Research|July 14, 2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics studyE Krasniqi, A Sacconi, D Marinelli, et al.
Expert Review of Vaccines|April 12, 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesP Vici, L Pizzuti, L Mariani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2020
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burdenD Marinelli, M Mazzotta, S Scalera, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2022
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinomaS Scalera, B Ricciuti, M Mazzotta, et al.
Pageof 9